The current stock price of ALGN is 157.78 USD. In the past month the price increased by 14.31%. In the past year, price decreased by -32.5%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| COO | COOPER COS INC/THE | 19.86 | 16.31B | ||
| SOLV | SOLVENTUM CORP | 14.37 | 14.80B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 22.6 | 4.99B | ||
| LNTH | LANTHEUS HOLDINGS INC | 10.74 | 4.25B | ||
| HAE | HAEMONETICS CORP/MASS | 17.65 | 3.97B | ||
| ICUI | ICU MEDICAL INC | 17.75 | 3.49B | ||
| XRAY | DENTSPLY SIRONA INC | 7.18 | 2.26B | ||
| UFPT | UFP TECHNOLOGIES INC | 25.35 | 1.69B | ||
| STAA | STAAR SURGICAL CO | N/A | 1.32B | ||
| NEOG | NEOGEN CORP | 19.95 | 1.30B | ||
| EMBC | EMBECTA CORP | 3.95 | 686.97M | ||
| BVS | BIOVENTUS INC - A | 12.2 | 595.87M |
Align Technology, Inc. is a medical device company, which engages in the design, manufacture, and market of orthodontics, restorative, and aesthetic dentistry products. The company is headquartered in Tempe, Arizona and currently employs 20,945 full-time employees. The company went IPO on 2001-01-26. The firm provides Align Digital Platform. Its segments include Clear Aligner, and Imaging Systems and CAD/CAM Services (Systems and Services). The Clear Aligner segment consists of comprehensive products, non-comprehensive products and non-case products. Its comprehensive products include Invisalign Comprehensive and Invisalign First. The firm's non-case products include retention products, Invisalign training and adjusting tools. The company offers up to four sets of custom clear aligners called Vivera retainers. The Systems and Services segment consists of its iTero intraoral scanning systems. Its services include subscription software, disposables, rentals, leases and pay per scan services.
ALIGN TECHNOLOGY INC
410 North Scottsdale Road, Suite 1300
Tempe ARIZONA 95134 US
CEO: Joseph M. Hogan
Employees: 20945
Phone: 14084701000
Align Technology, Inc. is a medical device company, which engages in the design, manufacture, and market of orthodontics, restorative, and aesthetic dentistry products. The company is headquartered in Tempe, Arizona and currently employs 20,945 full-time employees. The company went IPO on 2001-01-26. The firm provides Align Digital Platform. Its segments include Clear Aligner, and Imaging Systems and CAD/CAM Services (Systems and Services). The Clear Aligner segment consists of comprehensive products, non-comprehensive products and non-case products. Its comprehensive products include Invisalign Comprehensive and Invisalign First. The firm's non-case products include retention products, Invisalign training and adjusting tools. The company offers up to four sets of custom clear aligners called Vivera retainers. The Systems and Services segment consists of its iTero intraoral scanning systems. Its services include subscription software, disposables, rentals, leases and pay per scan services.
The current stock price of ALGN is 157.78 USD. The price increased by 0.6% in the last trading session.
ALGN does not pay a dividend.
ALGN has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
ALIGN TECHNOLOGY INC (ALGN) currently has 20945 employees.
ALIGN TECHNOLOGY INC (ALGN) has a market capitalization of 11.32B USD. This makes ALGN a Large Cap stock.
The outstanding short interest for ALIGN TECHNOLOGY INC (ALGN) is 4.48% of its float.
ChartMill assigns a technical rating of 5 / 10 to ALGN. When comparing the yearly performance of all stocks, ALGN is a bad performer in the overall market: 76.11% of all stocks are doing better.
ChartMill assigns a fundamental rating of 6 / 10 to ALGN. ALGN scores excellent points on both the profitability and health parts. This is a solid base for a good stock.
Over the last trailing twelve months ALGN reported a non-GAAP Earnings per Share(EPS) of 9.67. The EPS increased by 3.76% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 9.51% | ||
| ROA | 6.07% | ||
| ROE | 9.57% | ||
| Debt/Equity | 0 |
24 analysts have analysed ALGN and the average price target is 184.44 USD. This implies a price increase of 16.9% is expected in the next year compared to the current price of 157.78.
For the next year, analysts expect an EPS growth of 11.17% and a revenue growth 0.42% for ALGN